{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:26:27Z","timestamp":1759134387501},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:00:00Z","timestamp":1349913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00066-012-0169-1","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T14:04:32Z","timestamp":1349791472000},"page":"982-989","source":"Crossref","is-referenced-by-count":18,"title":["Toxicity and outcome of pelvic IMRT for node-positive prostate cancer"],"prefix":"10.1007","volume":"188","author":[{"given":"A.-C.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00fctjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Belka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,11]]},"reference":[{"key":"169_CR1","unstructured":"(NCCN) NCCN (2011) Prostate cancer. NCCN Clinical Practice Guidelines in Oncology. Vol Version 4.2011: http:\/\/www.nccn.org. MS-18"},{"key":"169_CR2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2008.12.082","volume":"75","author":"Aizer","year":"2009","unstructured":"Aizer AA, Yu JB, McKeon AM et al (2009) Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 75:1344\u20131349","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2009.08.042","volume":"93","author":"Alongi","year":"2009","unstructured":"Alongi F, Fiorino C, Cozzarini C et al (2009) IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 93:207\u2013212","journal-title":"Radiother Oncol"},{"key":"169_CR4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.06.011","volume":"84","author":"Arcangeli","year":"2007","unstructured":"Arcangeli S, Saracino B, Petrongari MG et al (2007) Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol 84:148\u2013155","journal-title":"Radiother Oncol"},{"key":"169_CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijrobp.2005.02.050","volume":"63","author":"Ashman","year":"2005","unstructured":"Ashman JB, Zelefsky MJ, Hunt MS et al (2005) Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63:765\u2013771","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2009.05.006","volume":"77","author":"Bayley","year":"2010","unstructured":"Bayley A, Rosewall T, Craig T et al (2010) Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer. Int J Radiat Oncol Biol Phys 77:477\u2013483","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.meddos.2007.05.006","volume":"33","author":"Bayouth","year":"2008","unstructured":"Bayouth JE, Pena J, Culp L et al (2008) Feasibility of IMRT to cover pelvic nodes while escalating the dose to the prostate gland: dosimetric data on 35 consecutive patients. Med Dosim 33:180\u2013190","journal-title":"Med Dosim"},{"key":"169_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","volume":"360","author":"Bolla","year":"2002","unstructured":"Bolla M, Collette L, Blank L et al (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360:103\u2013106","journal-title":"Lancet"},{"key":"169_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1464-410X.2007.06954.x","volume":"100","author":"Bolla","year":"2007","unstructured":"Bolla M, Descotes JL, Artignan X et al (2007) Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer. BJU Int 100(Suppl 2):44\u201347","journal-title":"BJU Int"},{"key":"169_CR10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2011.02.024","volume":"59","author":"Briganti","year":"2011","unstructured":"Briganti A, Karnes RJ, Da Pozzo LF et al (2011) Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol 59:832\u2013840","journal-title":"Eur Urol"},{"key":"169_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2008.03.015","volume":"73","author":"Chung","year":"2009","unstructured":"Chung HT, Xia P, Chan LW et al (2009) Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 73:53\u201360","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","volume":"84","author":"Cozzarini","year":"2007","unstructured":"Cozzarini C, Fiorino C, Di Muzio N et al (2007) Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 84:164\u2013170","journal-title":"Radiother Oncol"},{"key":"169_CR13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.eururo.2009.01.046","volume":"55","author":"Da","year":"2009","unstructured":"Da Pozzo LF, Cozzarini C, Briganti A et al (2009) Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Eur Urol 55:1003\u20131011","journal-title":"Eur Urol"},{"key":"169_CR14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ijrobp.2009.08.043","volume":"78","author":"Deville","year":"2011","unstructured":"Deville C, Both S, Hwang WT et al (2011) Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 78:763\u2013772","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR15","doi-asserted-by":"crossref","unstructured":"Deville C, Vapiwala N, Hwang WT et al (2011) Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys (Epub ahead of print)","DOI":"10.1016\/j.ijrobp.2011.04.041"},{"key":"169_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/153303460900800505","volume":"8","author":"Engels","year":"2009","unstructured":"Engels B, Soete G, Tournel K et al (2009) Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity. Technol Cancer Res Treat 8:353\u2013359","journal-title":"Technol Cancer Res Treat"},{"key":"169_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1160\/nukmed-0075","volume":"46","author":"Eschmann","year":"2007","unstructured":"Eschmann SM, Pfannenberg AC, Rieger A et al (2007) Comparison of 11C-choline-PET\/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin 46:161\u2013168","journal-title":"Nuklearmedizin"},{"key":"169_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","volume":"75","author":"Fiorino","year":"2009","unstructured":"Fiorino C, Alongi F, Perna L et al (2009) Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 75:29\u201335","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2008.12.047","volume":"75","author":"Fonteyne","year":"2009","unstructured":"Fonteyne V, De Gersem W, De Neve W et al (2009) Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer. Int J Radiat Oncol Biol Phys 75:1013\u20131020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijrobp.2006.08.082","volume":"67","author":"Ganswindt","year":"2007","unstructured":"Ganswindt U, Paulsen F, Corvin S et al (2007) Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys 67:347\u2013355","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ijrobp.2010.01.012","volume":"79","author":"Ganswindt","year":"2011","unstructured":"Ganswindt U, Schilling D, Muller AC et al (2011) Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys 79:1364\u20131372","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0212-6982(09)71350-3","volume":"28","author":"Garcia","year":"2009","unstructured":"Garcia JR, Soler M, Blanch MA et al (2009) PET\/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer. Rev Esp Med Nucl 28:95\u2013100","journal-title":"Rev Esp Med Nucl"},{"key":"169_CR23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00066-012-0081-8","volume":"188","author":"Geier","year":"2012","unstructured":"Geier M, Astner ST, Duma MN et al (2012) Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol 188:410\u2013416","journal-title":"Strahlenther Onkol"},{"key":"169_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000139880","volume":"41","author":"Goldner","year":"2008","unstructured":"Goldner G, Potter R (2008) Radiotherapy in lymph node-positive prostate cancer patients\u2014a potential cure? Single institutional experience regarding outcome and side effects. Front Radiat Ther Oncol 41:68\u201376","journal-title":"Front Radiat Ther Oncol"},{"key":"169_CR25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00066-010-2211-5","volume":"187","author":"Goldner","year":"2011","unstructured":"Goldner G, Potter R, Kranz A et al (2011) Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy. Strahlenther Onkol 187:202\u2013205","journal-title":"Strahlenther Onkol"},{"key":"169_CR26","first-page":"236","volume":"Oncol","author":"Guerrero","year":"2010","unstructured":"Guerrero Urbano T, Khoo V, Staffurth J et al (2010) Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol (R Coll Radiol) 22:236\u2013244","journal-title":"Clin"},{"key":"169_CR27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","volume":"167","author":"Heidenreich","year":"2002","unstructured":"Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167:1681\u20131686","journal-title":"J Urol"},{"key":"169_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/02841860600781781","volume":"45","author":"Hong","year":"2006","unstructured":"Hong TS, Tome WA, Jaradat H et al (2006) Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Acta Oncol 45:717\u2013727","journal-title":"Acta Oncol"},{"key":"169_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijrobp.2007.06.079","volume":"71","author":"John","year":"2008","unstructured":"John SS, Zietman AL, Shipley WU et al (2008) Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases. Int J Radiat Oncol Biol Phys 71:43\u201347","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"169_CR31","unstructured":"Leitlinienprogramm Onkologie der AWMW DKeVu, e.V DK (2011) Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. German S3-Guideline 2011;Version 2.0-1. Aktualisierung 1\u2013236"},{"key":"169_CR32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2008.10.050","volume":"75","author":"McCammon","year":"2009","unstructured":"McCammon R, Rusthoven KE, Kavanagh B et al (2009) Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys 75:413\u2013420","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2010.09.023","volume":"82","author":"Meijer","year":"2012","unstructured":"Meijer HJ, Debats OA, Kunze-Busch M et al (2012) Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer. Int J Radiat Oncol Biol Phys 82:175\u2013183","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","volume":"341","author":"Messing","year":"1999","unstructured":"Messing EM, Manola J, Sarosdy M et al (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781\u20131788","journal-title":"N Engl J Med"},{"key":"169_CR35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","volume":"7","author":"Messing","year":"2006","unstructured":"Messing EM, Manola J, Yao J et al (2006) Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7:472\u2013479","journal-title":"Lancet Oncol"},{"key":"169_CR36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2007.11.060","volume":"71","author":"Muren","year":"2008","unstructured":"Muren LP, Wasbo E, Helle SI et al (2008) Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. Int J Radiat Oncol Biol Phys 71:1034\u20131041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2010.02.025","volume":"97","author":"Perna","year":"2010","unstructured":"Perna L, Alongi F, Fiorino C et al (2010) Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy. Radiother Oncol 97:71\u201375","journal-title":"Radiother Oncol"},{"key":"169_CR38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2009.01.048","volume":"76","author":"Pervez","year":"2010","unstructured":"Pervez N, Small C, MacKenzie M et al (2010) Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 76:57\u201364","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00066-011-2249-z","volume":"187","author":"Pinkawa","year":"2011","unstructured":"Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479\u2013484","journal-title":"Strahlenther Onkol"},{"key":"169_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02841860701558849","volume":"47","author":"Sanguineti","year":"2008","unstructured":"Sanguineti G, Endres EJ, Parker BC et al (2008) Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol 47:301\u2013310","journal-title":"Acta Oncol"},{"key":"169_CR41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1464-410X.2008.07592.x","volume":"102","author":"Schilling","year":"2008","unstructured":"Schilling D, Schlemmer HP, Wagner PH et al (2008) Histological verification of 11C-choline-positron emission\/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102:446\u2013451","journal-title":"BJU Int"},{"key":"169_CR42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2008.05.023","volume":"54","author":"Schumacher","year":"2008","unstructured":"Schumacher MC, Burkhard FC, Thalmann GN et al (2008) Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54:344\u2013352","journal-title":"Eur Urol"},{"key":"169_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijrobp.2011.06.087","volume":"78","author":"Sheets","year":"2011","unstructured":"Sheets N, Goldin GH, Meyer AM et al (2011) Comparative long-term morbidity of intensity modulated vs. conformal radiation therapy (RT) for prostate cancer: a SEER-medicare analysis. Int J Radiat Oncol Biol Phys 78:43","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.coc.0000256705.93441.a0","volume":"30","author":"Su","year":"2007","unstructured":"Su AW, Jani AB (2007) Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique. Am J Clin Oncol 30:215\u2013219","journal-title":"Am J Clin Oncol"},{"key":"169_CR45","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.21947","volume":"106","author":"Swanson","year":"2006","unstructured":"Swanson GP, Thompson IM, Basler J (2006) Treatment options in lymph node-positive prostate cancer. Cancer 106:2531\u20132539","journal-title":"Cancer"},{"key":"169_CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijrobp.2010.07.111","volume":"78","author":"Tward","year":"2010","unstructured":"Tward JD, Shrieve CD (2010) Radiotherapy is correlated with superior survival in clinically node positive prostate cancer. Int J Radiat Oncol Biol Phys 78:31","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"169_CR47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1464-410X.2006.06166.x","volume":"97","author":"Weckermann","year":"2006","unstructured":"Weckermann D, Goppelt M, Dorn R et al (2006) Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =\u200910\u00a0ng\/mL and biopsy Gleason score of < or =\u20096, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 97:1173\u20131178","journal-title":"BJU Int"},{"key":"169_CR48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00066-010-2195-1","volume":"187","author":"Weidner","year":"2011","unstructured":"Weidner AM, Lin EN van, Dinter DJ et al (2011) Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse. Strahlenther Onkol 187:206\u2013212","journal-title":"Strahlenther Onkol"},{"key":"169_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1748-717X-6-44","volume":"6","author":"Wurschmidt","year":"2011","unstructured":"Wurschmidt F, Petersen C, Wahl A et al (2011) [18F]fluoroethylcholine-PET\/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET\/CT-positive lymph nodes. Radiat Oncol 6:44\u201351","journal-title":"Radiat Oncol"},{"key":"169_CR50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0302-2838(02)00257-9","volume":"42","author":"Zurlo","year":"2002","unstructured":"Zurlo A, Collette L, Tienhoven G van et al (2002) Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863. Eur Urol 42:125\u2013132","journal-title":"Eur Urol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-012-0169-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0169-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:41:01Z","timestamp":1562251261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-012-0169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1007\/s00066-012-0169-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,11]]}}}